Peak Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/18/2024
Peak Pharmaceuticals Stock Forecast and Price Target
Peak Pharmaceuticals's stock is projected to advance by 0 from the previous closing price if it reaches the average target of $0.00 by the year's end, as reputable analysts recently projected. This potential downside is calculated on a high-end estimate of $0.00 and a low-end estimate of $0.00. If you want to invest in PKPH stock, you might also want to take a look at how its competitors are doing.
N/A
.jpg)
Peak Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
Peak Pharmaceuticals's EBIT has increased by 1500.00% In the last two years, going from $-10000.00 to $-160.00k. According to 0 analysts, Peak Pharmaceuticals's EBIT will fall by 66.07% in the next year, reaching $-54.29k. Professionals believe that By 2030, Peak Pharmaceuticals's EBIT will fall to $-107.65k – a 32.72% decrease from its current value.
.jpg)